Abstract:
A method for processing plant matter, which involves applying a processing composition including at least one biological agent selected from: bacteria including a DNA sequence, referred to as 16S rDNA, coding for the 16S ribosomal RNA of the bacterium, which is 100% homologous with SEQ ID NO. 1, culture media in which bacteria have grown which include the 16S rDNA sequence that is 100% homologous with SEQ ID NO. 1 and which are substantially free of the bacteria, the culture media including polynucleotides having a DNA sequence which is 100% homologous with SEQ ID NO. 1, and in which the bacteria are selected from bacteria that are consistent with the strain filed and registered on 7 Apr. 2011 with number 1-4467 before the French National Collection of Microorganism Cultures (CNCM) of the Pasteur Institute, and mutant bacteria of the filed strain.
Abstract:
An aqueous liquid medium for analyzing, purifying or separating species in an element having walls or for treating the walls of an element. The medium includes at least a polymer consisting of several polymeric segments. The polymer is of the irregular block-copolymer or irregular comb-like polymer type and has on the average at least three junction points between polymeric segments of different chemical or topological nature. The medium may be used in methods for analyzing, purifying or separating species and methods for treating an element to be contacted with a fluid and/or species contained in the fluid during preservation, transport, analysis, purification or separation of the fluid.
Abstract:
The present invention concerns the use of a compound having the following formula (I), for the preparation of a polymer. The present invention also concerns the polymers obtained from polymerization of compound of formula (I), and their processes of preparation.
Abstract:
The present invention concerns compound of formula (I): wherein: A represents an electron-withdrawing group; D represents an electron-donating group; X is selected from the group consisting of: O, S and NR, wherein R is selected from the group consisting of: H, an alkyl group preferably comprising from 1 to 20 carbon atoms, an aryl group preferably comprising from 6 to 22 carbon atoms, and a heteroaryl group; n is an integer from 1 to 4; m is an integer from 1 to 6, preferably from 1 to 4; formula (II) represents a condensed bicyclic aromatic radical comprising from 6 to 22 carbon atoms, and from 1 to 3 heteroatom(s) selected from the group consisting of: N, S and O; the OH group being in ortho position of the condensed bicyclic aromatic radical relative to the formula (III) radical. The present invention also concerns its uses, and light devices comprising them.
Abstract:
The present invention concerns a method for obtaining a functional parameter of a muscle having a part, the method comprising the steps of: a) applying ultrasound waves to the muscle, b) collecting the ultrasound waves retrodiffused by the muscle at a plurality of times, to obtain collected ultrasound waves, c) determining a first plurality of values representative of stiffness values of one part at a first plurality of times by using the collected ultrasound waves, d) determining a second plurality of values representative of deformation values of said part at a second plurality of times by using the collected ultrasound waves, and e) deducing at least one functional parameter based on the first plurality of values and the second plurality of values. The invention also concerns a corresponding device.
Abstract:
The present invention relates to nanoparticles comprising at least one platinum compound comprising at least platinum and at least one rare earth, said rare earth being present in an oxidized form, notably useful for the catalysis of the reduction reaction of dioxygen (RRO) in an acid medium, and methods for the preparation thereof.The invention also relates to a cathode comprising said nanoparticles and its use notably in a hydrogen fuel cell, also called PEMFC.
Abstract:
The present invention relates to the use of polymers of the following formula (I): wherein: A1i represents a radical alkylene divalent comprising from 2 to 20 carbon atoms; A2i represents a radical alkylene divalent comprising from 2 to 20 carbon atoms; X1i is chosen from the group consisting of: —S—, —CH2— and a bond; Y represents H, a phenyl group or an alkyl group comprising from 1 to 10 carbon atoms; i represents an integer varying from 1 to n; n represents an integer comprised from 2 to 1,000; provided that the total number of carbon atoms of the radicals A2i, X1i et A1i is greater than or equal to 8; as additives in a polymeric matrix chosen from the group consisting of matrices of polyester, poly(vinyl chloride), polyurethane, polyamide, poly(alkyl acrylate), poly(alkyl methacrylate), polystyrene and polyolefin, said polymer of formula (I) being different from poly(ricinoleic acid).
Abstract:
A process for preparing a magnetic talcous composition including mineral particles, referred to as magnetic talcous particles, having a non-zero magnetic susceptibility, in which, during an oxidative contacting step, talcous particles chosen from the group formed from 2:1 lamellar silicates having a zero electric charge are brought into contact with particles including at least one magnetic iron oxide chosen from the group formed from magnetite and maghemite, the magnetic particles having a mean equivalent diameter of between 1 nm and 50 nm. A magnetic talcous composition including mineral particles, referred to as magnetic talcous particles, having a non-zero magnetic susceptibility, at least 20% by weight of talcous particles and at least 0.5% by weight of magnetic particles is also described.
Abstract:
The present invention relates to a capsule comprising at least one cell with hematopoietic potential, said capsule being formed with a liquid core and at least one gelled shell encapsulating totally the liquid core at its periphery, to the use of such a capsule for producing ex vivo enucleated erythroid cells as well as an ex vivo method for producing enucleated erythroid cells using said capsule.
Abstract:
A compound is of formula (I): in which A1 and A1′ are independently from each other a linear or branched alkylene radical including from 1 to 20 carbon atom(s); A2 is in particular a linear or branched alkylene radical including from 1 to 200 carbon atom(s); A3 is H or a linear or branched alkyl radical including from 1 to 15 carbon atom(s) and R1 and R1′ are independently from each other H or a linear or branched alkyl radical comprising from 1 to 20 carbon atom(s). The compounds of formula (I) can be used in particular for the preparation of poly(hydroxyurethane)s and epoxy resins.